- Denis joined Andera Partners in 2017.
- Before that, he worked as an investment banking analyst in Michel Dyens & Co healthcare practice.
- Denis holds a Master’s degree in Biotechnology Engineering from Sup’Biotech Paris and a postgraduate degree in Biopharmaceutical Management from ESCP Europe.
- He speaks French and English.
600 parts on my saxophone
Investments of Denis
Small molecules for the treatment of cancer
Small molecules for the treatment of hepatitis B and NASH
Small molecule for the treatment of behavioral and psychological symptoms of dementia in AD
Gene therapy for the treatment of rare diseases in infants
Medical Micro Instruments
Robotic assisted microsurgery platform
Naturally occurring molecule for the treatment of fibrotic diseases in the renal and cardiovascular
Small molecules as a therapeutic treatment for RSV infection
Development of a non-invasive valve replacement technology